Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 4 Open-market sale VP, Corp Controller and CAO sold 798 shares at $26.51 ($21,152)
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale SVP, GC & Corporate Secretary sold 1,350 shares at $27.40 ($36,990)
  7. 4 Open-market sale Senior Vice President, R&D sold 1,125 shares at $27.40 ($30,825)
  8. 4 Open-market sale Chief Commercial Officer sold 1,125 shares at $27.40 ($30,825)
  9. 4 Open-market sale Chief Financial Officer sold 1,238 shares at $27.40 ($33,921)
  10. 4 Open-market sale Chief Executive Officer sold 4,813 shares at $27.40 ($131,876)
  11. SC 13G Stake Amended Statement of Ownership
  12. 4 Open-market sale VP, Corp Controller and CAO sold 934 shares at $24.58 ($22,955)
  13. 4 Open-market sale Senior Vice President, R&D sold 1,875 shares at $24.98 ($46,838)
  14. 4 Open-market sale Chief Commercial Officer sold 1,875 shares at $24.98 ($46,838)
  15. 4 Open-market sale SVP, GC & Corporate Secretary sold 2,250 shares at $24.98 ($56,205)
  16. 4 Open-market sale Chief Financial Officer sold 2,063 shares at $24.98 ($51,534)
  17. 4 Open-market sale Chief Executive Officer sold 7,873 shares at $24.98 ($196,668)
  18. 4 Open-market sale SVP, GC & Corporate Secretary sold 5,000 shares at $27.40 ($137,000)
  19. 4 Open-market sale Senior Vice President, R&D sold 2,500 shares at $27.40 ($68,500)
  20. 4 Open-market sale Chief Financial Officer sold 7,500 shares at $27.40 ($205,500)

Page 27 of 65 · 1,286 filings